| Literature DB >> 35799822 |
Xiaoyi Xin1, Yu Zhang1, Massimiliano Gaetani2,3, Susanna L Lundström2,3, Roman A Zubarev2,3, Yuan Zhou4, Dale P Corkery1, Yao-Wen Wu1.
Abstract
Chemical modification of proteins is enormously useful for characterizing protein function in complex biological systems and for drug development. Selective labeling of native or endogenous proteins is challenging owing to the existence of distinct functional groups in proteins and in living systems. Chemistry for rapid and selective labeling of proteins remains in high demand. Here we have developed novel affinity labeling probes using benzotriazole (BTA) chemistry. We showed that affinity-based BTA probes selectively and covalently label a lysine residue in the vicinity of the ligand binding site of a target protein with a reaction half-time of 28 s. The reaction rate constant is comparable to the fastest biorthogonal chemistry. This approach was used to selectively label different cytosolic and membrane proteins in vitro and in live cells. BTA chemistry could be widely useful for labeling of native/endogenous proteins, target identification and development of covalent inhibitors. This journal is © The Royal Society of Chemistry.Entities:
Year: 2022 PMID: 35799822 PMCID: PMC9214888 DOI: 10.1039/d1sc05974b
Source DB: PubMed Journal: Chem Sci ISSN: 2041-6520 Impact factor: 9.969
Fig. 1(a) Reactive groups used in affinity labeling. (b) Schematic illustration of affinity labeling using BTA chemistry for selective protein modification. (c–e) Compounds used for labeling FKBP12 (c), GRAMD1A (d) and carbonic anhydrases (CAs) (e) in this study.
Fig. 2In vitro labeling of FKBP12 protein. (a) SDS-PAGE and western blotting analysis of labeling reaction of 5 μM FKBP12 with 10 μM 1. (b) Kinetics of labeling reactions of 5 μM FKBP12 using 10 μM 1 (red) vs. LDNASA (blue). The solid line shows the fitting to a single-exponential equation for determining t1/2. Error bars represent standard deviation of three independent experiments. (c) The crystal structure of the FKBP12-SLF complex (PDB ID: 1FKG). The labelling sites of 1 are marked as red (Lys52, the major labeling site) and blue (Lys35, the minor labelling site). SLF is shown in green sticks.
Fig. 3(a) SDS-PAGE and western blotting analysis of FKBP12 labeling with 1 or LDNASA (2.5–10 μM) for 5 min in HeLa cell lysates supplemented with 2 μM recombinant FKBP12. (b) HeLa cells labeled with 1 were subjected to immunoprecipitation using streptavidin beads. Endogenous FKBP12 was visualized using an antibody against FKBP12. Data are representative of three independent experiments. (c) SDS-PAGE and in-gel fluorescence analysis of the labeling of 5 μM GRAMD1A (StART domain) with 10 μM 2. CBB: Coomassie brilliant blue staining. (d) Kinetics of the labeling reaction shown in (c). The solid line shows the fitting to an equation for determining the rate constant of second-order reaction (ESI†). Error bars represent standard deviation of three independent experiments.
Fig. 4Labeling of endogenous CA12 using 3. (a) Representative confocal fluorescent images of MCF7 cells treated with 3 in the absence and the presence of EZA. Nuclei were counterstained with Hoechst 33342. Scale bars, 10 μm. (b) Quantification of fluorescein fluorescence intensity from (a). Data were shown as mean ± sd from three biologically independent experiments. Data points represent individual cells pooled from the three independent experiments (n > 100 cells). Significance was determined from biological replicates using a one-way ANOVA with Tukey's multiple comparisons tests. **p = 0.0014, ***p = 0.0009. (c) Western blot analysis of MCF7 cells treated with 3 in the absence and the presence of EZA. (d) MCF7 cells labeled with 3 were subjected to immunoprecipitation using the anti-FITC antibody. CA12 and the fluorescein-labeled protein were visualized using antibodies against CA12 and FITC, respectively. Data are representative of three independent experiments.